GO:0140970 AIM2 inflammasome complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140970 describes the biological process of aggregation, arrangement and bonding of components to form the AIM2 inflammasome complex.
• AIM2 is a cytosolic sensor that assembles an inflammasome in response to double-stranded DNA, leading to caspase-1 activation and inflammatory cytokine release.
• AIM2 can form higher-order complexes with pyrin and ZBP1 to drive PANoptosis, a lytic cell death pathway integrating pyroptosis, apoptosis and necroptosis.
• Assembly of the AIM2 inflammasome is a highly regulated process involving oligomerization of AIM2, recruitment of ASC and pro-caspase-1.
• Dysregulated AIM2 inflammasome assembly is implicated in neurodegenerative diseases, inflammatory degeneration and cancer.
• Studying GO:0140970 requires advanced models such as CRISPR knockout, knock-in and single-molecule imaging to dissect molecular steps.
Description
The AIM2 inflammasome is a multiprotein complex that assembles in the cytosol in response to double-stranded DNA (dsDNA) and serves as a key innate immune sensor. The process of its assembly, formally annotated as GO:0140970, involves the aggregation, arrangement and bonding of AIM2, ASC and pro-caspase-1 into a functional platform that activates inflammatory caspases. This assembly is critical for host defense against pathogens and for detecting aberrant self-DNA, but its dysregulation contributes to a range of inflammatory and neurodegenerative disorders. Understanding the molecular mechanisms of AIM2 inflammasome complex assembly is therefore essential for developing targeted therapies. Recent studies have revealed that AIM2 can also interact with pyrin and ZBP1 to form larger PANoptosome complexes, expanding its role beyond canonical inflammasome signaling. Moreover, single-molecule analyses have provided unprecedented detail on the stepwise assembly of AIM2, highlighting the importance of oligomerization and filament formation. This article synthesizes current knowledge on GO:0140970, covering its definition, key genes, regulatory mechanisms, disease relevance, and state-of-the-art research methods including CRISPR-based models.
AIM2 inflammasome complex assembly At A Glance
| GO ID | GO:0140970 |
|---|---|
| GO term | AIM2 inflammasome complex assembly |
| Ontology | biological_process |
| Synonym | None |
| Major function | Assembly of a multiprotein complex that senses cytosolic dsDNA and activates caspase-1 |
| Key components | AIM2, ASC (PYCARD), pro-caspase-1 |
| Cellular location | Cytosol |
| Associated processes | Innate immunity, PANoptosis, inflammatory cytokine release |
What Is GO:0140970?
GO:0140970, AIM2 inflammasome complex assembly, is defined as the aggregation, arrangement and bonding together of a set of components to form the AIM2 inflammasome complex. In simpler terms, it is the process by which the protein AIM2, upon binding to cytosolic dsDNA, recruits the adaptor ASC and pro-caspase-1 to form a functional inflammasome platform that triggers inflammatory responses.
Why Is AIM2 inflammasome complex assembly Important in Cell Biology?
AIM2 inflammasome complex assembly is a central event in innate immunity, enabling the detection of cytosolic DNA from pathogens or damaged self-tissues. Proper assembly is crucial for host defense, but aberrant activation drives inflammatory pathologies, including neurodegenerative diseases and intervertebral disc degeneration. Understanding this process at molecular resolution can inform therapeutic strategies targeting inflammasome-driven inflammation.
• Essential for sensing cytosolic double-stranded DNA and mounting an inflammatory response.
• Drives caspase-1 activation and maturation of IL-1β and IL-18.
• Forms a platform for PANoptosis, a lytic cell death pathway integrating pyroptosis, apoptosis and necroptosis.
• Implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Contributes to inflammatory degeneration in intervertebral disc disease.
• Potential target for therapeutic intervention in inflammatory and autoimmune disorders.
• Requires precise regulation to avoid autoinflammation.
• Studied using advanced techniques like single-molecule imaging and CRISPR screens.
What Happens During AIM2 inflammasome complex assembly?
AIM2 sensing of cytosolic dsDNA
In simple terms: AIM2 detects DNA that leaks into the cell's main compartment.
AIM2 binds to double-stranded DNA in the cytosol via its HIN domain, which relieves autoinhibition and triggers a conformational change that promotes oligomerization. This initial sensing step is critical for initiating assembly and is tightly regulated to prevent spurious activation.
AIM2 oligomerization and filament formation
In simple terms: AIM2 molecules cluster together into long chains.
Upon DNA binding, AIM2 molecules oligomerize into filaments through PYD-PYD interactions, forming a scaffold for downstream adaptor recruitment. Single-molecule studies have revealed that AIM2 assembly is a cooperative process, with nucleation and elongation phases.
Recruitment of ASC and pro-caspase-1
In simple terms: The clustered AIM2 recruits two other proteins to complete the complex.
The PYD domain of AIM2 interacts with the PYD domain of ASC, which then recruits pro-caspase-1 via CARD-CARD interactions, forming the complete inflammasome complex. This step leads to caspase-1 activation and downstream inflammatory signaling.
Higher-order PANoptosome assembly
In simple terms: AIM2 can join with other sensors to form a larger death-inducing platform.
AIM2 can form a complex with pyrin and ZBP1 to drive PANoptosis, a lytic cell death pathway that integrates features of pyroptosis, apoptosis and necroptosis. This higher-order assembly expands the functional repertoire of AIM2 beyond canonical inflammasome signaling.
Regulation by post-translational modifications and cellular machinery
In simple terms: Cells use chemical tags and transport systems to control assembly.
Inflammasome assembly is regulated by phosphorylation, ubiquitination and interactions with molecular motors such as HDAC6, which mediates aggresome-like transport of inflammasome components. These regulatory layers ensure appropriate activation and prevent excessive inflammation.
Key Genes Involved in GO:0140970 AIM2 inflammasome complex assembly
The following genes and proteins are central to AIM2 inflammasome complex assembly and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AIM2 | Cytosolic dsDNA sensor; nucleates inflammasome assembly | Core component; knockout models used to study DNA sensing |
| PYCARD (ASC) | Adaptor protein linking AIM2 to caspase-1 | Essential for inflammasome assembly; KO blocks signaling |
| CASP1 | Inflammatory caspase; activated by inflammasome | Effector of cytokine maturation and pyroptosis |
| ZBP1 | Sensor that interacts with AIM2 to drive PANoptosis | Mediates cross-talk between cell death pathways |
| MEFV (Pyrin) | Sensor that forms complexes with AIM2 | Involved in PANoptosis and autoinflammatory diseases |
| NLRP3 | Related inflammasome sensor | Can co-assemble with AIM2 in PANoptosis |
| NLRC4 | Related inflammasome sensor | Contributes to integrated inflammasome responses |
| NEK7 | Kinase essential for NLRP3 activation | Potential regulator of AIM2-related assembly |
| HDAC6 | Mediates aggresome-like transport of inflammasomes | Regulates spatial organization of assembly |
| TRIM56 | E3 ubiquitin ligase; regulates cGAS-STING | Indirectly affects AIM2 via DNA sensing pathways |
| ATR | DNA damage response kinase | Part of TRIM56-ATR complex; links to inflammation |
| CGAS | Cytosolic DNA sensor | Parallel pathway to AIM2 for DNA sensing |
| STING1 | Adaptor in cGAS-STING pathway | Cross-regulates AIM2 inflammasome |
| IL1B | Pro-inflammatory cytokine | Readout of AIM2 inflammasome activation |
| IL18 | Pro-inflammatory cytokine | Readout of AIM2 inflammasome activation |
| GSDMD | Pore-forming protein in pyroptosis | Executes cell death downstream of AIM2 |
| RIPK3 | Kinase in necroptosis | Component of PANoptosome with AIM2 |
| CASP8 | Apoptotic caspase | Participates in PANoptosis |
How Is AIM2 inflammasome complex assembly Regulated?
AIM2 inflammasome assembly is tightly regulated at multiple levels. Post-translational modifications, including phosphorylation and ubiquitination, control AIM2 oligomerization and ASC recruitment. The kinase NEK7, known for NLRP3 regulation, may also influence AIM2-related assembly through shared pathways. HDAC6 mediates aggresome-like transport of inflammasome components, facilitating spatial organization and assembly. Additionally, the TRIM56-ATR complex regulates cytosolic DNA sensing and can impact AIM2 activation indirectly. These regulatory mechanisms ensure that AIM2 inflammasome assembly occurs only in response to appropriate danger signals, preventing autoinflammation.
AIM2 inflammasome complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AIM2 | Neurodegenerative diseases (Alzheimer's, Parkinson's) | AIM2 KO mice; neuronal cell lines |
| AIM2 | Inflammatory degeneration (intervertebral disc) | AIM2 KO in disc cells; overexpression |
| PYCARD | Autoinflammatory syndromes | ASC KO and knock-in models |
| ZBP1 | PANoptosis-related pathologies | ZBP1 KO mice; AIM2-ZBP1 double KO |
| CASP1 | Inflammasome-driven inflammation | Caspase-1 KO; point mutations |
AIM2 inflammasome in neurodegenerative diseases
Aberrant AIM2 inflammasome assembly contributes to neuroinflammation in Alzheimer's disease, Parkinson's disease and other neurodegenerative conditions. Chronic activation leads to neuronal damage and cognitive decline, making AIM2 a potential therapeutic target.
AIM2 and inflammatory degeneration
In intervertebral disc degeneration, disassembly of the TRIM56-ATR complex promotes cytoDNA/cGAS/STING-dependent inflammation, which can intersect with AIM2 inflammasome activation. This highlights the role of AIM2 in sterile inflammatory diseases.
AIM2 in PANoptosis and host defense
AIM2 forms complexes with pyrin and ZBP1 to drive PANoptosis, a critical host defense mechanism against pathogens. Dysregulation of this process can lead to excessive cell death and tissue damage.
Therapeutic targeting of AIM2 inflammasome
Inhibiting AIM2 inflammasome assembly is a promising strategy for treating inflammatory diseases. Small molecules and biologics targeting AIM2 or its downstream effectors are under investigation.
From AIM2 inflammasome complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does AIM2 drive DNA-induced inflammation? | AIM2 knockout cell lines and mice |
| How does AIM2 oligomerization occur? | Point mutations in AIM2 PYD domain; knock-in |
| What is the role of ASC in assembly? | ASC knockout and tagged knock-in for imaging |
| Can AIM2 form PANoptosomes? | AIM2-ZBP1-pyrin triple knockout; overexpression |
| How is AIM2 regulated by phosphorylation? | Phospho-mimetic and phospho-dead point mutants |
| What genes modulate AIM2 assembly? | CRISPR library screening |
How to Study the AIM2 inflammasome complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-molecule imaging | AIM2 oligomerization dynamics | Mechanistic studies of assembly |
| CRISPR knockout screening | Genes regulating AIM2 assembly | Discovery of novel regulators |
| Affinity proteomics | Protein interactions and modifications | Identification of complex components |
| Caspase-1 activity assay | Inflammasome activation | Functional validation |
| IL-1β ELISA | Cytokine release | Readout of inflammasome activation |
| Pyroptosis assay | Cell death | Downstream effect of AIM2 |
| Immunofluorescence | ASC speck formation | Visualization of assembly |
| Western blot | Protein cleavage and expression | Validation of knockout/knock-in |
Single-molecule imaging of AIM2 assembly
Single-molecule fluorescence techniques allow real-time visualization of AIM2 oligomerization on DNA, revealing nucleation and elongation kinetics. This method provides unprecedented detail on the assembly process.
CRISPR screening for regulators of AIM2 inflammasome
Genome-wide CRISPR knockout screens can identify genes that positively or negatively regulate AIM2 inflammasome assembly. Hits can be validated with targeted knockouts and functional assays.
Proteomic analysis of inflammasome complexes
Affinity purification coupled with mass spectrometry can identify components and post-translational modifications of the AIM2 inflammasome. This approach reveals dynamic changes during assembly.
Functional assays for inflammasome activation
Caspase-1 activity, IL-1β secretion and pyroptosis assays are standard readouts for AIM2 inflammasome function. These can be combined with knockout or knock-in models to dissect pathways.
How CRISPR Can Be Used to Study GO:0140970 AIM2 inflammasome complex assembly
Knockout
CRISPR knockout of AIM2, PYCARD or CASP1 abolishes inflammasome assembly and downstream signaling, providing a clean background to study specific contributions. Knockout cell lines are essential for validating off-target effects and for rescue experiments.
Point Mutation
Point mutations in AIM2 (e.g., in the HIN or PYD domain) can disrupt DNA binding or oligomerization, allowing structure-function analysis. Phospho-mimetic mutations can probe regulatory phosphorylation sites.
Knock-in
Knock-in of tagged AIM2 (e.g., GFP or HA) enables live-cell imaging and proteomic studies of inflammasome assembly. Knock-in of disease-associated variants can model human pathologies.
Overexpression
Overexpression of AIM2 or its components can drive spontaneous inflammasome assembly, useful for studying activation mechanisms and for screening inhibitors. Inducible overexpression systems provide temporal control.
How EDITGENE Supports AIM2 inflammasome complex assembly Research
Researchers studying AIM2 inflammasome complex assembly-related genes often need to determine whether a candidate gene is causally involved in the assembly process or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for AIM2 inflammasome complex assembly research.
Frequently Asked Questions About AIM2 inflammasome complex assembly
What is AIM2 inflammasome complex assembly?
It is the biological process (GO:0140970) by which the AIM2 protein, upon binding cytosolic dsDNA, aggregates with ASC and pro-caspase-1 to form a functional inflammasome complex.
What genes are involved in AIM2 inflammasome complex assembly?
Key genes include AIM2, PYCARD (ASC), CASP1, and modulators such as ZBP1, MEFV, and HDAC6.
How is AIM2 inflammasome assembly regulated?
It is regulated by post-translational modifications, oligomerization dynamics, and interactions with proteins like HDAC6 and NEK7.
What diseases are associated with AIM2 inflammasome?
Neurodegenerative diseases, inflammatory degeneration, and autoinflammatory conditions are linked to dysregulated AIM2 inflammasome assembly.
What methods are used to study AIM2 inflammasome assembly?
Single-molecule imaging, CRISPR screening, proteomics, and functional assays such as caspase-1 activity and IL-1β ELISA.
Can CRISPR be used to study AIM2 inflammasome?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect AIM2 inflammasome assembly.
What is the role of AIM2 in PANoptosis?
AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis, a lytic cell death pathway integrating pyroptosis, apoptosis, and necroptosis.
What is the GO term for AIM2 inflammasome assembly?
The Gene Ontology term is GO:0140970, AIM2 inflammasome complex assembly.
How does AIM2 sense DNA?
AIM2 binds double-stranded DNA via its HIN domain, which triggers a conformational change and oligomerization.
What cell models are available for AIM2 inflammasome research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression cell models for AIM2 and related genes.
Conclusion
AIM2 inflammasome complex assembly (GO:0140970) is a fundamental innate immune process that detects cytosolic DNA and triggers inflammatory responses. Its dysregulation is implicated in a growing list of human diseases, from neurodegeneration to inflammatory degeneration. Advanced CRISPR models and single-molecule techniques are unraveling the molecular details of this assembly, offering new opportunities for therapeutic intervention. EDITGENE supports researchers with tailored CRISPR services to accelerate discoveries in this field.
References
- 1. Lee S et al.. 2021. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence.. Nature 597(7876):415-419 PMID: 34471287
- 2. Oh S et al.. 2023. Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis.. Cell Mol Immunol 20(12):1513-1526 PMID: 38008850
- 3. Singh J et al.. 2023. Inflammasome assembly in neurodegenerative diseases.. Trends Neurosci 46(10):814-831 PMID: 37633753
- 4. Pandeya A et al.. 2024. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes.. Trends Mol Med 30(1):74-88 PMID: 37977994
- 5. Sharma M et al.. 2023. Assembly mechanism of the inflammasome sensor AIM2 revealed by single molecule analysis.. Nat Commun 14(1):7957 PMID: 38042863
- 6. He Y et al.. 2016. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.. Nature 530(7590):354-7 PMID: 26814970
- 7. Zhang W et al.. 2024. Disassembly of the TRIM56-ATR complex promotes cytoDNA/cGAS/STING axis-dependent intervertebral disc inflammatory degeneration.. J Clin Invest 134(6) PMID: 38488012
- 8. Magupalli VG et al.. 2020. HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation.. Science 369(6510) PMID: 32943500
